Hubungan Kadar High Sensitivity- C Reactive Protein (Hs-Crp) Dengan Volume Infark Dan Outcome Fungsional Pada Pasien Stroke Iskemik Akut

DAFTAR PUSTAKA

Ahuja, J., Basu, A. 2012. Study of C-Reactive Protein Level in Patients of
Acute Ishemic Stroke and Its Correlation With Serum Lipid Profile.
Intenational Journal of Health Sciences and Research; 2(3):40-48.
American Joint Committee on Cancer. 2003. Comparison Guide: Fifth
Versus
Sixth
Edition.
Available
at
:
http://www.cancerstaging.org/products/ajccguide.pdf
Arenillas, J.F., Sabin, J.A., Molina, C.A., Chacon, P., Montaner, J., Rovira,
A., et al. 2003. C- Reactive Protein Predicts Further Ischemic
Events in First Ever Transient Ischemic Attack or Stroke Patients
with Intracranial Large Artery Occlusive Disease.Stroke. 34:24632470.
Attyẻ, A., Boncoeur-Martel, M.P., Maubon, A., Mounayer, C., Couratier,
P., Labrunie, A., Le Bas, J.F. 2012. Diffusion-Weighted Imaging
infarct volume and neurologic outcomes after ischemic stroke. J
Neuroradiol. May;39(2):97-103

Barrett, K.M., Ding, Y.H., Wagner, D.P., Kallmes, D.F., Johnston, K.C.
2009. Change in Diffusion-Weighted Imaging Infarct Volume
Predicts Neurologic Outcome at 90 Days Results of the Acute
Stroke Accurate Prediction (ASAP) Trial Serial Imaging Substudy.
Stroke. 40:2422-2427.
Black, S., Kusher, I., Samols, D. 2004. Minireview : C-reactive protein. J.
Biol. Chem; 279:48487-48490.
Braunwald, E. Congestive Heart Failure and Cor Pulmonale. In: Kasper,
D.L., Braunwald, E., Fauci, A.S., Hauser, S.L., Longo, D.L.,
Jameson, J.L., editors. Harrison’s Manual of Medicine 16th edition.
New York. McGraw-Hill; 2005. p648-652
Canova, C.R., Courtin, C., Reinhart, W.H. C-reactive protein (CRP) in
cerebro-vsculsr events. Atherosclerosis. 1999 Nov 1;147(1):49-53
Caplan, L.R. 2009. Caplan’s Stroke: A Clinical Approach. 4th ed.
Saunders. Elsevier Philadelphia.p 89-92 CDC/NHSN Protocol
Clarifications. 2013.
CDC/NHSN Surveillance Definitions for spesific Types of Infections. 17-1 –
60.

63


Ćorić, J., Pašić, A., Panjeta, M., Mujić, J. 2012.Evaluation of high
sensitivity C – reactive protein assay in cerebrospinal fluid on the
Dimension RxL analyzer. Journal of Health Sciences; 2(1):13-6
Dar, M.S., Pandith, A.A., Samee, A.S., Sultan, M., Yousuf, A., Mudassar,
S. Hs-CRP : A potential Marker for Hypertension in Khasmiri
Population. Indian Journal of Clinical Biochemistry, 2010 / 25 (2)
208-212
Dewan, K.R., Rana, P.V.S. 2011. C-Reactive Protein and Early Mortality in
Acute Ischemic Stroke. Kathmandu Univ Med J; 36(4):252-5.
Di Napoli, M., Elkind, M. S., Godoy, D.A., Singh, P.,Papa, F., PopaWagner, A. 2011. Role of C-Reactive Protein in Cerebrovascular
Disease. Expert Rev Cardiovasc Ther. 9(12):1565-1584.
Di Napoli, M., Papa, F., Bocola, V. 2001. Prognostic Influence of Increase
C-Reactive Protein and Fibrinogen Levels in Ischemic Stroke.
Stroke.32:133-138.
Di Napoli, M., Papa, F., Bocola V. 2001. C-Reactive Protein in Ischemic
Stroke : An Independent Prognostic Factor. Stroke. 32: 917-92
Di Napoli, M., Schwaninger, M., Cappelli, R., Ceccarelli, E., Gianfilipo, G.,
Donati, C., et al. 2005. Evaluation of C-Reactive Protein
Measurement for Assessing the Risk and Prognosisin Ischemic

Stroke : a Statement for Health Care Proffesionals From the CRP
Pooling Project Members. Stroke. 36: 1316-1329.
Elkind, M.S.V. 2010. Inflammatory Mechanism of Stroke. Stroke.41: S3S8.
Farhoudi, M., Najafi-Nesheli, M., Hashemilar, M., Mahmoodpoor, A.,Ehsan
Sharifipour, E., Baradaran, B., et al. 2013. Effect of IMOD™ on the
inflammatory process after acute ischemic stroke: a randomized
clinical trial. Daru; 21(1): 26.
Furlan, A.J. 2001. Perfusion –Weighted CT in Acute MCA Stroke :
Teaching Old Dogs New Tricks. Stroke. 32 : 2027-28.
Fuster, V., Ryden, L.E., Cannom, D.S., Crijns, H.J., Curtis, A.B.,
Ellenbogen, K.A., et al. 2006. ACC/AHA/ESC 2006 guidelines for
the management of patients with atrial fibrillation. European Heart
Journal. 27: 1979-2030

Ghabaee, M., Zandieh, A., Mohebbi, S., Fakhri, M., Sadeghian, H., Divani,
F., et al. 2013. Predictive Ability of C-Reactive Protein for Early
mortality after ischemic stroke; Comparison with NIHSS Score. Acta
Neurologica Belgica.
Gofir, A. 2009. Manajemen Stroke. Evidence Based Medicine. Pustaka
Cendekia Press. Yogyakarta.

Hamidon, B B., Sapiah, S., Nawawi, H., Raymond, A A. 2004. The
Prognostic Value of C-Reactive Protein (CRP) Levels in Patients
with Acute Ischaemic Stroke. Med J Malaysia; Vol 59 (5): 631-7.
Harukuni, I., Bhardwaj, A. 2006. Mechanisms of Brain Injury after Global
Cerebral Ischemia. Neurol Clin 24: 1–21
Hertog, H.M., Rossum, J.A., Van der Worp,H.B., Van Gemert, H.M.A., de
Jonge,R., Koudstall,P.J., Dippel,D.W. 2009. C-Reactive protein in
the very early phase of acute ischemic stroke: association with poor
outcome and death. J Neurol.259:2003-2008.
Hirschfield, G.M., Pepys, M,B. 2003. C-Reactive Protein and
Cardiovascular disease: New Insight from an Old Molecule. QJ
Med; 96:793-807.
Husain, T.M., Kim, D.H. 2002. C-Reactive Protein and Erythrocyte
Sedimentation Ratein Orthopaedics. The University of Pennsylvania
Orthopaedic Journal15: 13–16
Idicula TT, Brogger J, Naess H, Waje-Andreassen U, Thomassen L. 2009.
Admission C - reactive protein after acute ischemic stroke is
associated with stroke severity and mortality: The `Bergen stroke
study. BMC Neurology 9:18.
Jialal, I., Devaraj, S. 2001. Inflammation and AtherosclerosisThe Value of

the High-Sensitivity C-Reactive Protein Assay as a Risk Marker Am
J ClinPathol;116 (Suppl 1):S108-S115
Johnson, K. 2012. Liver Failure. Digestive Disorders Health Center.
Available at: http://www.webmd.com/digestive-disorders/digestivediseases-liver-failure
Kara, H., Akinci, M., Degirmenci, S.,Bayir, A., Ak, A., Nayman A., et al.
High-sensitivity
C-reactive
protein,
lipoprotein-related
phospholipase A, and acute ischemic stroke. Neuropsychiatric
Disease and Treatment 2014:10 1451–1457

KDIGO Clinical Practice Guideline for Acute Kidney Injury. 2012. Kidney
International Supplements. 2:19–36
Lakhan, E.S., Kirchgessner, A., Hofer, M. 2009. Inflammatory mechanisms
in ischemic stroke: therapeutic approaches. Journal of Translational
Medicine 7:97.
Lambert, M. 2011. AHA/ASA Guidelines on Prevention of Recurrent
Stroke. Am Fam Physician. Apr 15;83(8):993-100
Madiyono, B., Moeslichan, M., Budiman, I., Purwanto, S.H. 2008.

Perkiraan Besar Sampel. Dalam : Sastroasmoro S, Ismael S, editor.
Dasar-dasar Metodologi Penelitian Klinis. Jakarta : Sagung Seto;
hal 302-331
Marquardt, L., Ruf, A., Mansmann, U., Winter, R., Buggle, F., Kallenberg,
K., Grau, A. J. 2005. Inflammatory response after acute ischemic
stroke. J Neurol Sci. 236(1-2):65-71.
Masotti, L., Ceccarelli, E., Forconi, S., Cappelli, R. 2005. Prognostic role of
C-Reactive Protein in very old patients with acute ischemic stroke.
Misbach, J., Lamsudin, R., Aliah, A., Basyiruddin, Suroto, Nurimaba, N., et
al. Kelompok Studi Stroke Perhimpunan Dokter Spesialis Saraf
Indonesia. 2011. Guideline Stroke. Perdossi. Jakarta.
Misbach, J. 2011. Stroke : Aspek diagnostik, patofisiologi, manajemen.
Badan Penerbit FKUI.
Muir, K.W., Weir, J.C., Alwan, W., Squire, B.I., Lees, K.R. 1999. CReactive Protein and Outcome After Ischemic Stroke. Stroke
30:981-985.
Nighoghossian, N., Wiart, M., Cakmak, S., Berthezene, Y., Derex, L., Cho,
T.H., et al. 2007. Inflamatory response after Ishemic Stroke: A
USPIO-Enhanced MRI study in Patients. Stroke.38:303-307.
Ormstad, H.,Aass, H.C.,Lund-Sorensen, N., Amthor, K.F., Sandvik, L.
2011. Serum levels of cytokines and C-reactive protein in acute

ischemic stroke patients, and their relationship to stroke
lateralization, type, and infarct volume. . J Neurol.258(4):677-685
Osmani A., Durrani R., Ara J. 2010. Comparison of Outcome in Different
Types of Stroke Due to Cerebral Ischemia. Journal of the College of
Physicians and Surgeons Pakistan.20(1):42-46

Pantano, P., Caramia, F., Bozzao, L., Dieler C., and von Kummer, R.
1999. Delayed Increase in Infarct Volume After Cerebral Ischemia :
Correlations with Thrombolytic Treatment and Clinical Outcome.
Stroke. 30:502-507
Pepys, M.B. The acute phase response and C-Reactive Protein. Oxford
Textbook of Medicine. 2nd ed. Oxford, UK: Oxford University Press;
1995:1527-1533.
Rahman, M.M., Rabim, M.A., Nath, R.K., Al-Mahmood, A.K., Mollah, F.H.
2011. Prognostic role of C-reactive protein in acute stroke.
Bangladesh Journal of Medical Science; 10(1): 29-33.
Rajeshwar K, Kaul S, Al-Hazzani,A., Babu MS, Balakrishna N, Sharma V,
Jyothy A, Munshi A. 2012. C-reactive protein and nitric oxide levels
in ischemic stroke and its subtypes: correlation with clinical
outcome. Inflammation; 35(3):978-84

Roger, L.V., Go, S.A., Lloyd-Jones, D.M., Adams, J.R., Berry,J.D., Brown,
T.D., et al. 2011. Heart Disease and Stroke Statistics—2011
Update A Report From the American Heart Association.
Circulation;123:e18-e209.
Roudbary, S.A., Saadat, F., Forganpharast, K., Sohrabnejad,R. 2011.
Serum C- Reactive Protein Level as a Biomarker for differentiation
of Ischemic Stroke from hemorrhagic Stroke. Acta Medica Iranica;
49(3):149-152.
Sacco, R.L., Kasner, S.E., Broderick, J.P., Caplan, L.R.,Culebras, A.,
Elkind, M.S.V.,et al. 2013. An Update Defenition of Stroke for the
21st Century: a Statement for Healthcare Professionals from the
American Heart Association/American Stroke Association. Stroke;
44:2064-2089.
Saver, J.L., Johnston, K.C., Homer, D., Wityk, R., Koroshetz, W.,
Truskowski, L.L., Haley, E.C. 1999. Infarct Volume as a Surrogate
or Auxiliary Outcome Measure in Ischemic Stroke Clinical Trials.
Semple, S.j. 2006. C-reactive Protein –Biological function, cardiovascular
disease and physical exercise. SAJSM; 18(1):24-28.
Shaikh, M.K., Makhija, P., Baloch, Z.A.Q., Mughal, M.F., Devrajani, B.R.,
Shaikh, S., Das, T. 2011. C-Reactive Protein in Patients with

Ischemic Stroke. World Applied Sciences Journal 15(9): 1220-1224.

Sims, J.R., Gharai, L.R., Schaefer, P.W., Vangel, M., Rosenthal, E.S., Lev,
M.H., and Schwamm, L.H. 2009. ABC/2 for rapid clinical estimate of
infarct, perfusion, and mismatch volumes. Neurology June 16.
Vol.72 no.24 2104-2110
Sjahrir, H. 2003. Stroke Iskemik. Yandira Agung Medan.
Smith, C.J., Emsley, H.C.A., Gavin, C.M., Georgiou, R.F., Vail, A.,
Barberan, E.M., et al. 2001. Peak plasma interleukin-6 and other
peripheral markers of inflammation in the first week of ischaemic
stroke correlate with brain infarct volume, stroke severity and longterm outcome. BMC Neurology.4:2.
Taheraghdam , A., Aminnejad, S., Pashapour, A., Rikhtegar, R., Ghabil,
K. 2013. Is there a correlation between hs-CRP levels and
functional outcome of Ischemic Stroke? Pak J Med Sci. 29(1):166169.
Truelsen, T., Piechonski-Jozwiak, B., Bonita, R., et al. 2006. Stroke
Incidence and Prevalence in Europe: a review of available data.
European Journal of Neurology. 13(6):581-589.
US Food and Drug Administration. Review criteria for assessmentof Creactive protein (CRP), high sensitivity C-reactive protein, and
cardiac
C-reactive

protein
(cCRP)
assays.
2005.
http://www.fda.gov/cdrh/oivd/guidance/1246.pdf
Weimar, C., Kurth, T., Kraywinkel, K., Wagner, M., Busse, O., Haberl, R.
L., Diener, H. S. 2002. Assessment of Functioning and Disability
After Ischemic Stroke. Stroke. 33:2053-2059.
Winbeck, K., Poppert, H., Etgen, T., Conrad, B., Sander, D. 2002.
Prognostic Relevance of Early C-Reactive protein Measurement
After Ischemic stroke. Stroke; 33: 2459-2464.
Youn, C.S., Choi,S.P., Kim,H.S., Oh, S.H., Jeong, W.J., Kim,J.H., Park,
K.N. 2012. Serum highly selective C-reactive protein concentration
is associated with the volume of ischemic tissue in acute ischemic
stroke. Am J Emerg Med 30(1):124-8

Dokumen yang terkait

Perbandingan Efek Kombinasi Aspirin Dan Simvastatin Terhadap Kadar High Sensitivity C-Reactive Protein (Hs-CRP) Dan Outcome Fungsional Pasien Stroke Iskemik Dengan Dan Tanpa Dislipidemia

2 78 152

Hubungan Kadar Adiponektin Dan Trigliserida Serum Dengan Volume Infark Dan Outcome Pada Pasien Stroke Iskemik Akut

1 65 128

Peranan High Sensitivity C-Reactive Protein (hs-CRP) pada Penyakit Jantung Koroner.

0 1 6

Hubungan Kadar High Sensitivity- C Reactive Protein (Hs-Crp) Dengan Volume Infark Dan Outcome Fungsional Pada Pasien Stroke Iskemik Akut

0 2 17

Hubungan Kadar High Sensitivity- C Reactive Protein (Hs-Crp) Dengan Volume Infark Dan Outcome Fungsional Pada Pasien Stroke Iskemik Akut

0 0 2

Hubungan Kadar High Sensitivity- C Reactive Protein (Hs-Crp) Dengan Volume Infark Dan Outcome Fungsional Pada Pasien Stroke Iskemik Akut

0 0 8

Hubungan Kadar High Sensitivity- C Reactive Protein (Hs-Crp) Dengan Volume Infark Dan Outcome Fungsional Pada Pasien Stroke Iskemik Akut

0 0 25

Hubungan Kadar High Sensitivity- C Reactive Protein (Hs-Crp) Dengan Volume Infark Dan Outcome Fungsional Pada Pasien Stroke Iskemik Akut

0 1 7

Perbandingan Efek Kombinasi Aspirin Dan Simvastatin Terhadap Kadar High Sensitivity C-Reactive Protein (Hs-CRP) Dan Outcome Fungsional Pasien Stroke Iskemik Dengan Dan Tanpa Dislipidemia

0 0 15

BAB I PENDAHULUAN 1. Latar Belakang - Perbandingan Efek Kombinasi Aspirin Dan Simvastatin Terhadap Kadar High Sensitivity C-Reactive Protein (Hs-CRP) Dan Outcome Fungsional Pasien Stroke Iskemik Dengan Dan Tanpa Dislipidemia

0 1 13